Cardiac magnetic resonance biomarkers for cardiovascular complications in diabetes: a systematic review and meta-analysis

• by Ning Li, Jitao Zhang, Yongyan Wang, Yugeng Li

• May 28, 2026

Validation of femoral pressure-derived assessment of effective arterial elastance in porcine ischemic cardiogenic shock

• by Oskar Kjærgaard Hørsdal, Nigopan Gopalasingam, Kristoffer Berg-Hansen, Roni Nielsen

• July 21, 2026

Oral Aleniglipron Reduced Weight at 36 Weeks

In a phase 2b trial, the highest dose produced an estimated 12% mean weight reduction vs 1% with placebo, although gastrointestinal adverse events were common.

• by Kathryn Wighton

• July 16, 2026

• 6 min

Pre–existing Comorbidities as Potential Risk Modifiers for New-Onset Myocarditis and Pericarditis following mRNA COVID-19 Vaccination in Males Aged 18–30 in the United States: A Disproportionality Analysis using VAERS Spontaneous Reporting Data

• by Mohammed Salah Salem, Yola Moride, Bernard Bégaud

• July 13, 2026